Observe Medical ASA: Business update and first quarter 2022 presentation
Oslo, 3 June 2022 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) today releases its first quarter results for 2022. Observe Medical has made progress across its medtech platform during the quarter, preparing and strengthening it for growth. The Company has also streamlined the organization and other operational synergies following the acquisition of Biim Ultrasound in January this year. Observe Medical has continued the roll-out of Biim, a patented, wireless, and pocketable ultrasound probe, across Fresenius Kidney Care’s educational centres throughout the US.